Overview

An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia

Status:
Terminated

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the long-term treatment efficacy, and safety of risperidone long-acting injection in participants with schizophrenia (psychiatric disorder with symptoms of emotional instability, detachment from reality, often with delusions and hallucinations, and withdrawal into the self).

Details

Lead Sponsor:

Xian-Janssen Pharmaceutical Ltd.

Treatments:

Antipsychotic Agents
Risperidone
Serotonin Uptake Inhibitors